Back

Epirubicin promotes coronary endothelial senescence and dysfunction with induction of pro-inflammatory and pro-thrombotic responses: role of the AT1R/NADPH oxidases/SGLT2 pro-oxidant pathway

11 May 2026 (08:30 - 09:15)
Organised by: Logo
Congress Presentation Part of: Frontiers in basic and translational heart failure research Cardiotoxicity of Drugs HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Mr Lior Axenbeck

Strasbourg (France)

6 More presentations in this session

Presentation thumbnail
The gut-heart axis: fecal microbiome shifts following SGLT2 inhibitor initiation in heart failure - a pilot study
Miss D. Teshuva (Tel Aviv, IL)
Abstract Slides Video
Presentation thumbnail
ACEI plus GLP1-RA or SGLT2i, as well as ARNI, exerted distinct protective effects against diabetic nephropathy and heart failure with preserved ejection fraction in eNOS-/- dbdb mice.
Doctor K. Yu (Nantong, CN)
Abstract Slides Video
Presentation thumbnail
Effects of sodium-glucose cotransporter 2 inhibitors on cardiac metabolism, assessed by phosphorus magnetic resonance spectroscopy, in patients with heart failure
Associate Professor P. Rubis (Krakow, PL)
Abstract Slides Video
Presentation thumbnail
The effect of ARNI and SGLT2i therapies on the inflammasome pathway in myocardial heart transplantation biobank samples.
Doctor D. Nagy (Budapest, HU)
Abstract Slides Video
Presentation thumbnail
Efficacy of interleukin-1 blockade for prevention of heart failure outcomes in patients with prior myocardial Infarction: a systematic review and meta-analysis of 10301 patients
Miss B. Tran (Debrecen, HU)
Abstract Slides Video

Access the full session

Session thumbnail
Frontiers in basic and translational heart failure research

The Event

Event poster

Heart Failure 2026

11 May 2026 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Epigenetic editing of chromatin readers rescues doxorubicin-induced endothelial senescence and vascular dysfunction
thumbnail
Congress Presentation
GLP1-RA associated with PCSK9i as new therapy of anthracycline-induced cardiotoxicity under exposure to Ox-LDL: biochemical and preclinical evidences
thumbnail
Congress Presentation
Sodium-glucose cotransporter 2 inhibitor Dapagliflozin reduces systemic H-FABP and monocyte-to-lymphocyte ratio in preclinical models of antracycline induced cardiotoxicity

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources